Skip to main content

Table 1 Comparison between the low versus high dose salbutamol groups and non-pulmonary organ dysfunction and mortality

From: Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury

Days alive and free

Low dose (n = 64)a

High dose (n = 22)a

p value

Cardiovascular

11.5 ± 2.6

13.2 ± 4.2

0.50

Renal

14.3 ± 2.9

16.0 ± 4.5

0.55

Hepatic

17.4 ± 2.8

19.6 ± 4.4

0.42

Hematological

15.9 ± 2.9

19.6 ± 4.5

0.10

Neurological

16.6 ± 2.6

19.0 ± 3.9

0.35

Mortality (%)

46.9%

50.0%

0.80

  1. aValues are mean ± standard error of the mean.